Document:

EX-10.4

 Exhibit 10.4 

BIODELIVERY SCIENCES INTERNATIONAL, INC. 

2011 EQUITY INCENTIVE PLAN 

NONQUALIFIED STOCK OPTION AGREEMENT 

FOR NON-EMPLOYEE DIRECTORS 

 

					
	Name of Optionee:	  	                                      
                                         
                 	  	
			
	Number of Shares:	  	                                      
              	  	
			
	Date of Grant:	  	                                      
              	  	
			
	Exercise Price:	  	                                      
              	  	
			
	Expiration Date:	  	                                      
              	  	

 1. As of the Date of Grant set forth above (the “Grant Date”), BioDelivery Sciences
International, Inc. (the “Company”) hereby grants a Stock Option (the “Option”) to the above-named Optionee pursuant to the BioDelivery Sciences International, Inc. 2011 Equity Incentive Plan as amended through the
date hereof (the “Plan”) and this Nonqualified Stock Option Agreement (this “Agreement”). The award of this Option (the “Award”) conveys to the Optionee the right to purchase from the Company up to
the number of shares of common stock, par value $.001, of the Company set forth above (the “Option Shares”), at an exercise price per share as set forth above. The Option awarded hereunder is intended to be a nonqualified stock
option and is specifically not intended to be treated as an Incentive Stock Option as such term is defined under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”). 

2. The rights of the Optionee, or of any other person entitled to exercise the Option, are and shall be governed by the terms and provisions
of the Plan. The Option is granted pursuant to the terms of the Plan, which is incorporated herein by reference as if set forth in full herein, and the Option shall in all respects be interpreted in accordance with the Plan. The
Company shall interpret and construe the Plan and this Agreement with respect to any issue arising thereunder or hereunder, and such interpretations and determinations by the Company shall be conclusive and will bind the parties hereto and any other
person claiming an interest hereunder. In the event of any conflict between the provisions of the Plan and of this Agreement, the provisions of the Plan shall prevail. Capitalized terms in this Agreement shall have the meaning specified in the Plan,
unless a different meaning is specified herein. 
 3. No portion of this Stock Option may be exercised until such portion shall have become
exercisable. The Options will vest and become exercisable in accordance with the following schedule, provided that the Optionee remains in continued service on the Company’s Board of Directors as of such vesting date:

							
	Incremental Number of
Options Vested	 	  	
Vesting Date	 
	 	                             (     
   %)	 	  	 	                            	 
	 	                             (     
   %)	 	  	 	                            	 
	 	                             (     
   %)	 	  	 	                            	 

 The Committee may at any time accelerate the vesting schedule specified herein. 

4. To the extent not previously exercised, the Option and all rights with respect thereto, shall terminate and become null and void when the
Option Term (hereinafter defined) expires. 
 5. The Option, once exercisable, may be exercised, in whole or in part, at any time or from
time to time prior to the Expiration Date set forth above (the “Option Term”). The Option Term is contingent upon the continued service of the Optionee on the Company’s Board of Directors. The unvested portion of an Option
shall expire upon termination of service. The vested portion of an Option shall remain exercisable for: 
 (a) one year
following termination of service by reason of such Optionee’s death or Disability (with the determination of Disability to be made by the Committee on a case by case basis), but not later than the expiration of the Option Term; 

(b) 90 calendar days following termination of service for any reason other than such Optionee’s death, Disability or
Retirement, and other than such Optionee’s termination of service for Cause, but not later than the expiration of the Option Term; or 

(c) the remainder of the Option Term following termination of service by reason of such Participant’s Retirement. 

Both the unvested and the vested portion of an Option shall immediately expire upon the termination of the Participant’s service by the Company for
Cause. 
 6. The Option may be exercised with respect to all or any part of the number of vested Option Shares by the giving of written or
electronic notice, in a manner specified by the Administrator (“Notice”), of the intent to exercise to the Company. The Notice shall specify the exercise date and the number of Option Shares as to which the Option is to be
exercised. Full payment of the Option exercise price shall be made on or before the exercise date specified in the Notice and shall be payable (i) in cash, check (subject to collection), or cash equivalent, and/or (ii) to the extent
permitted by the Committee, (A) through the delivery of vested Common Shares valued at the Closing Price at the time the Option is exercised (including, pursuant to procedures approved by the Committee, by means of attestation of
ownership of a sufficient number of Common Shares in lieu of actual delivery of such shares to the Company); provided, however, that such Common Shares are not subject to any pledge or other security interest,
(B) if there is a public market for the Common Shares at such time, by means of a broker-assisted “cashless exercise” pursuant to which the Company is delivered a copy of irrevocable instructions to a stockbroker to sell the Common Shares
otherwise deliverable upon the exercise of the Option and to deliver promptly to the Company an amount equal to the Exercise Price or (C) by a “net exercise” method whereby the Company withholds from the delivery of the Common
Shares for which the Option was exercised that number of Common Shares having a 

  
 2 

 
Closing Price equal to the aggregate Exercise Price for the Common Shares for which the Option was exercised. Any fractional Common Shares shall be settled in cash. The transfer to the Optionee
on the records of the Company or of the transfer agent of the Option Shares will be contingent upon (i) the Company’s receipt from the Optionee of the full purchase price for the Option Shares, as set forth above, (ii) the
fulfillment of any other requirements contained herein or in the Plan or in any other agreement or provision of laws, and (iii) the receipt by the Company of any agreement, statement or other evidence that the Company may require to
satisfy itself that the issuance of Stock to be purchased pursuant to the exercise of Stock Options under the Plan and any subsequent resale of the shares of Stock will be in compliance with applicable laws and regulations. If the Optionee fails to
pay for any of the Option Shares specified in the Notice, or fails to accept delivery of Option Shares, the Optionee’s right to purchase such Option Shares may be terminated by the Company. 

7. During the Optionee’s lifetime, the Option granted hereunder shall be exercisable only by the Optionee or by any guardian or legal
representative of the Optionee, and the Option shall not be transferable except, in the case of the death of the Optionee, by will or by the laws of descent and distribution, nor shall the Option be subject to attachment, execution or other similar
process. Any such guardian, legal representative or permitted transferee shall be bound by the terms of this Agreement. 
 8. The Company
may unilaterally amend the Award at any time if the Company determines, in its sole discretion that amendment is necessary or advisable in light of any applicable addition to or change in the Code, any regulations issued thereunder, or any Federal
or state securities law or other applicable law or regulation. 
 9. Unless and until this Stock Option shall have been exercised pursuant
to the terms hereof, the Company or the transfer agent shall have transferred the shares to the Optionee, and the Optionee’s name shall have been entered as the stockholder of record on the books of the Company, the Optionee shall have no
rights as a stockholder with respect to the Option Shares, and no adjustments shall be made for dividends of any kind or nature, distributions, or other rights for which the record date is prior to the date such stock is transferred. 

10. The Optionee acknowledges having received and read a copy of this Agreement and agrees to comply with all laws, rules and regulations
applicable to the Award and to the sale or other disposition of the Option Shares received. 
 11. In order to administer the Plan and this
Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents thereof (together, the “Relevant Companies”) may process any and all personal or professional data, including but
not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan and/or this Agreement (the “Relevant
Information”). By entering into this Agreement, the Optionee (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Optionee
may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any
jurisdiction in which the Relevant Companies consider appropriate. 

  
 3 

 
The Optionee shall have access to, and the right to change, the Relevant Information. Relevant Information will only be used in accordance with applicable law. 

12. Any notice to the Company provided for in this Agreement shall be addressed to it in care of its Secretary at its executive offices
located at 431 ParkLake Ave. Suite 225, Raleigh, NC, 27612, and any notice to the Optionee shall be addressed to the Optionee at the address currently shown on the payroll records of the Company. Any notice shall be deemed duly given if and when
properly addressed and posted by registered or certified mail, postage prepaid. 
 13. This Agreement does not constitute a contract of, or
an implied promise to continue, Optionee’s service or status with the Company or a subsidiary; and nothing contained in this Agreement shall confer upon Optionee the right to continue such service or status; nor does this Agreement affect the
right of the Company or any subsidiary to terminate Optionee’s service at any time. 
 14. This Agreement shall be governed by the laws
of the State of Delaware, without regard to the conflicts of laws principles thereof. 
 15. This Agreement constitutes the entire agreement
between the parties with respect to this Stock Option and supersedes all prior agreements and discussions between the parties concerning such subject matter. 

IN WITNESS WHEREOF, the Company has caused its duly authorized officers to execute this Agreement, and the Optionee has placed his or
her signature hereon, effective as of the Grant Date. 
  

			
	BIODELIVERY SCIENCES INTERNATIONAL, INC.
		
	By:	 	 
		 	Name: Herm Cukier
		 	Title: Chief Executive Officer

  

			
	ACCEPTED AND AGREED TO:
		
	By:	 	 
		 	[Name]
		 	Optionee

  
 4EX-10.5

 Exhibit 10.5 

BIODELIVERY SCIENCES INTERNATIONAL, INC. 

2011 EQUITY INCENTIVE PLAN 

RESTRICTED STOCK UNIT AWARD AGREEMENT 

FOR COMPANY EMPLOYEES 
  

					
			
	Name of Grantee:	  	                                      
                                         
                 	  	
			
	No. Of Restricted Stock Units:	  	                                      
              	  	
			
	Date of Grant:	  	                                      
              	  	

 1. As of the Date of Grant set forth above (the “Grant Date”), BioDelivery Sciences International,
Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (the “Award”) to the above-named Grantee pursuant to the 2011 Equity Incentive Plan as amended through the date hereof
(the “Plan”) and this Restricted Stock Unit Agreement (the “Agreement”). Each Restricted Stock Unit shall relate to one share of common stock, par value $.001 per share (the “Stock”) of the Company.

 2. The rights of the Grantee are and shall be governed by the terms and provisions of the Plan. The Award is granted pursuant to the
terms of the Plan, which is incorporated herein by reference as if set forth in full herein, and the Award shall in all respects be interpreted in accordance with the Plan. The Company shall interpret and construe the Plan and this Agreement with
respect to any issue arising thereunder or hereunder, and such interpretations and determinations by the Company shall be conclusive and will bind the parties hereto and any other person claiming an interest hereunder. In the event of any conflict
between the provisions of the Plan and of this Agreement, the provisions of the Plan shall prevail. Capitalized terms in this Agreement shall have the meaning specified in the Plan, unless a different meaning is specified herein. 

3. This Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of by the Grantee, and any shares of Stock
issuable with respect to the Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of until (i) the Restricted Stock Units have vested as set forth herein and (ii) shares of Stock have been issued
to the Grantee in accordance with the terms of the Plan and this Agreement. 
 4. The restrictions and conditions set forth above shall
lapse in accordance with the following schedule, provided that the Grantee remains in employment with the Company or any Subsidiary as of such date (each, a “Vesting Date”): 

 

							
	Incremental Number of
Restricted Stock Units Vested	 	  	
Vesting Date	 
	 	                             (     
   %)	 	  	 	                            	 
	 	                             (     
   %)	 	  	 	                            	 
	 	                             (     
   %)	 	  	 	                            	 

 The Committee may at any time accelerate the vesting schedule specified herein. 

 5. Except as otherwise provided in this Section 5, if the Grantee’s employment
with the Company or any Subsidiary terminates prior to the satisfaction of the vesting conditions set forth above, any Restricted Stock Units that have not vested as of such date shall automatically and without notice terminate and be forfeited, and
neither the Grantee nor any of his or her successors, heirs, assigns, or personal representatives will thereafter have any further rights or interests in such unvested Restricted Stock Units. Notwithstanding the foregoing, in the case of a
Grantee’s Retirement (as defined in the Plan), any unvested Restricted Stock Units shall become immediately vested and nonforfeitable and the date of such Retirement shall be deemed the Vesting Date with respect to such accelerated Restricted
Stock Units. 
 6. As soon as practicable following each Vesting Date (but in no event later than 30 days after the Vesting Date), the
Company shall issue to the Grantee the number of shares of Stock equal to the aggregate number of Restricted Stock Units that have vested pursuant to this Agreement on such date and the Grantee shall thereafter have all the rights of a stockholder
of the Company with respect to such shares. Notwithstanding the foregoing, in the event the Grantee becomes vested in the Restricted Stock Units on account of his or her Retirement, if the Grantee is a “specified employee” within the
meaning of Section 409A of the Internal Revenue Code of 1986, as amended and the regulations promulgated thereunder (“Section 409A”) upon his Retirement, the shares of Stock shall not be issued to the Grantee until the
seventh month after the Grantee’s “separation from service” within the meaning of Section 409A. 
 7. The Grantee
shall, not later than the date as of which the receipt of this Award becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the Committee for payment of any Federal, state, and local taxes
required by law to be withheld on account of such taxable event. The Company shall have the authority to cause the required minimum tax withholding obligation to be satisfied, in whole or in part, by withholding from shares of Stock to be issued to
the Grantee a number of shares of Stock with an aggregate Fair Market Value that would satisfy the withholding amount due. 
 8. This
Agreement shall be interpreted in such a manner that all provisions relating to the settlement of the Award are either exempt from the requirements of Section 409A as “short-term deferrals” as described in Section 409A or
compliant with Section 409A. 
 9. This Agreement does not constitute a contract of, or an implied promise to continue,
Grantee’s employment or status with the Company or a Subsidiary; and nothing contained in this Agreement shall confer upon Grantee the right to continue such employment, or status; nor does this Agreement affect the right of the Company or any
Subsidiary to terminate Grantee’s employment at any time. 
 10. This Agreement constitutes the entire agreement between the parties
with respect to this Award and supersedes all prior agreements and discussions between the parties concerning such subject matter. 
 11. In
order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents thereof (together, the “Relevant Companies”) may process any and all
personal or professional data, including but not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the

  
 2 

 
administration of the Plan and/or this Agreement (the “Relevant Information”). By entering into this Agreement, the Grantee (i) authorizes the Company to collect, process,
register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Grantee may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and
transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant Companies consider appropriate. The Grantee shall have access to, and the right to
change, the Relevant Information. Relevant Information will only be used in accordance with applicable law. 
 12. Any notice to the Company
provided for in this Agreement shall be addressed to it in care of its Secretary at its executive offices located at 431 ParkLake Ave. Suite 225, Raleigh, NC, 27612, and any notice to the Grantee shall be addressed to the Grantee at the address
currently shown on the payroll records of the Company. Any notice shall be deemed duly given if and when properly addressed and posted by registered or certified mail, postage prepaid. 

13. This Agreement shall be governed by the laws of the State of Delaware, without regard to the conflicts of laws principles thereof. 

IN WITNESS WHEREOF, the Company has caused its duly authorized officers to execute this Agreement, and the Optionee has placed his or
her signature hereon, effective as of the Grant Date. 
  

			
	BIODELIVERY SCIENCES INTERNATIONAL, INC.
		
	By:	 	 
		 	Name: Herm Cukier
		 	Title: Chief Executive Officer

  

			
	ACCEPTED AND AGREED TO:
		
	By:	 	 
		 	[Name]
		 	Grantee

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}]]